Rucaparib (phosphate)

Clear Filter

Results for "Rucaparib (phosphate)_NCI-H1573": 1001 gene sets

Name
Rucaparib (phosphate)_NCI-H1573 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H1573 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_C32 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_C32 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HepG2/C3A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HepG2/C3A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SW 900 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SW 900 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_LOX-IMVI Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_LOX-IMVI drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_A-172 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_A-172 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_BT-474 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_BT-474 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_LS 180 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_LS 180 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_CFPAC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_CFPAC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_Hs 766T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_Hs 766T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SK-MEL-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SK-MEL-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_A498 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_A498 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HT-29 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HT-29 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HEC-1-A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HEC-1-A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_A549 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_A549 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_AsPC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_AsPC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SNU-423 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SNU-423 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SHP-77 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SHP-77 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_A-427 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_A-427 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_CHP-212 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_CHP-212 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_MIA PaCa-2 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_MIA PaCa-2 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HOP62 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HOP62 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HS-578T Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HS-578T drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SW1417 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SW1417 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SW480 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SW480 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_RKO Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_RKO drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_PANC-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_PANC-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_J82 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_J82 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_hTERT-HPNE Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_hTERT-HPNE drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_C-33 A Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_C-33 A drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_AN3 CA Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_AN3 CA drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SW 1088 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SW 1088 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_LoVo Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_LoVo drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_KATO III Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_KATO III drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_Panc 03.27 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_Panc 03.27 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_HCT15 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_HCT15 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SW 1271 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SW 1271 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_H4 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_H4 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_RPMI-7951 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_RPMI-7951 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_COLO 205 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_COLO 205 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SW48 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SW48 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rucaparib (phosphate)_SNU-1 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rucaparib (phosphate)_SNU-1 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
RUCAPARIB PHOSPHATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the RUCAPARIB PHOSPHATE drug from theDGIdb Drug Targets 2026 dataset.
Rucaparib Gene Set From DeepCoverMOA Drug Mechanisms of Action proteins with high or low expression in Rucaparib relative to other proteins from the DeepCoverMOA Drug Mechanisms of Action dataset.
RUCAPARIB Gene Set From DGIdb Drug Targets 2026 interacting proteins for the RUCAPARIB drug from theDGIdb Drug Targets 2026 dataset.
RUCAPARIB METABOLITE M324 Gene Set From DGIdb Drug Targets 2026 interacting proteins for the RUCAPARIB METABOLITE M324 drug from theDGIdb Drug Targets 2026 dataset.
RUCAPARIB CAMSYLATE Gene Set From DGIdb Drug Targets 2026 interacting proteins for the RUCAPARIB CAMSYLATE drug from theDGIdb Drug Targets 2026 dataset.
Benproperine (phosphate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benproperine (phosphate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benproperine (phosphate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
adenosine 3'-phosphate-5'-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical adenosine 3'-phosphate-5'-phosphate from the curated CTD Gene-Chemical Interactions dataset.
3'-Phosphate-Adenosine-5'-Phosphate Sulfate Gene Set From DrugBank Drug Targets interacting proteins for the 3'-Phosphate-Adenosine-5'-Phosphate Sulfate drug from the curated DrugBank Drug Targets dataset.
protein-pyridoxal-5-phosphate linkage via peptidyl-n6-pyridoxal phosphate-l-lysine Gene Set From GO Biological Process Annotations 2015 genes participating in the protein-pyridoxal-5-phosphate linkage via peptidyl-n6-pyridoxal phosphate-l-lysine biological process from the curated GO Biological Process Annotations 2015 dataset.
sedoheptulose-7-phosphate:d-glyceraldehyde-3-phosphate glyceronetransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the sedoheptulose-7-phosphate:d-glyceraldehyde-3-phosphate glyceronetransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
Glycerol-3-phosphate O-acyltransferase/Dihydroxyacetone phosphate acyltransferase Gene Set From InterPro Predicted Protein Domain Annotations proteins predicted to have the Glycerol-3-phosphate O-acyltransferase/Dihydroxyacetone phosphate acyltransferase protein domain from the InterPro Predicted Protein Domain Annotations dataset.
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine Gene Set From GO Biological Process Annotations 2023 genes participating in the protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine biological process from the curated GO Biological Process Annotations 2023 dataset.
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate Gene Set From GO Biological Process Annotations 2023 genes participating in the fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate biological process from the curated GO Biological Process Annotations 2023 dataset.
tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate Gene Set From GO Biological Process Annotations 2023 genes participating in the tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate biological process from the curated GO Biological Process Annotations 2023 dataset.
glucose 6-phosphate:inorganic phosphate antiporter activity Gene Set From GO Molecular Function Annotations 2023 genes performing the glucose 6-phosphate:inorganic phosphate antiporter activity molecular function from the curated GO Molecular Function Annotations 2023 dataset.
hexose-phosphate:inorganic phosphate antiporter activity Gene Set From GO Molecular Function Annotations 2023 genes performing the hexose-phosphate:inorganic phosphate antiporter activity molecular function from the curated GO Molecular Function Annotations 2023 dataset.
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine Gene Set From GO Biological Process Annotations 2025 genes participating in the protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine biological process from the curated GO Biological Process Annotations 2025 dataset.
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate Gene Set From GO Biological Process Annotations 2025 genes participating in the fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate biological process from the curated GO Biological Process Annotations 2025 dataset.
glucose 6-phosphate:phosphate antiporter activity Gene Set From GO Molecular Function Annotations 2025 genes performing the glucose 6-phosphate:phosphate antiporter activity molecular function from the curated GO Molecular Function Annotations 2025 dataset.
hexose-phosphate:phosphate antiporter activity Gene Set From GO Molecular Function Annotations 2025 genes performing the hexose-phosphate:phosphate antiporter activity molecular function from the curated GO Molecular Function Annotations 2025 dataset.
deoxynucleoside-phosphate kinase activity, ATP as phosphate donor Gene Set From GO Molecular Function Annotations 2025 genes performing the deoxynucleoside-phosphate kinase activity, ATP as phosphate donor molecular function from the curated GO Molecular Function Annotations 2025 dataset.
(R)-Verapamil (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fedratinib (hydrochloride hydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fedratinib (hydrochloride hydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Methyl aminolevulinate (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Methyl aminolevulinate (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cysteamine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cysteamine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fingolimod (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fingolimod (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rutin (trihydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rutin (trihydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Irinotecan (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Irinotecan (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Esmolol (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Esmolol (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Atazanavir (sulfate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Atazanavir (sulfate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Vinblastine (sulfate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Vinblastine (sulfate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Niclosamide (olamine)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Niclosamide (olamine)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berbamine (dihydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berbamine (dihydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Clonidine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Clonidine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lenalidomide (hemihydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lenalidomide (hemihydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Thyroxine (sodium salt pentahydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Thyroxine (sodium salt pentahydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Topotecan (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Topotecan (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Norepinephrine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Norepinephrine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Belumosudil (mesylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Belumosudil (mesylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ivabradine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ivabradine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Idarubicin (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Idarubicin (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pyridoxine (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pyridoxine (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Palmatine (chloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Palmatine (chloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (mesylate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (mesylate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenytoin (sodium)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenytoin (sodium)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Perindopril (erbumine)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Perindopril (erbumine)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Citalopram (hydrobromide)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Citalopram (hydrobromide)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dapagliflozin ((2S)-1,2-propanediol, hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lidocaine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lidocaine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Mitoxantrone (dihydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Mitoxantrone (dihydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ouabain (Octahydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ouabain (Octahydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Benztropine (mesylate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Benztropine (mesylate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bisoprolol (hemifumarate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bisoprolol (hemifumarate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pasireotide (acetate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pasireotide (acetate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Berberine (chloride hydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Berberine (chloride hydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the S-Adenosyl-L-methionine (disulfate tosylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Carbidopa (monohydrate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Carbidopa (monohydrate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Azithromycin (hydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Azithromycin (hydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tirabrutinib (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tirabrutinib (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Crizotinib (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Crizotinib (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Osimertinib (mesylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Osimertinib (mesylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Phenylephrine (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Phenylephrine (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Nafamostat (mesylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Nafamostat (mesylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pravastatin (sodium)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pravastatin (sodium)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Goserelin (acetate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Goserelin (acetate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
(R)-Verapamil (hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the (R)-Verapamil (hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fluvoxamine (maleate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fluvoxamine (maleate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Balsalazide (sodium hydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Balsalazide (sodium hydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Selinexor _NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Selinexor _NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Sivelestat (sodium tetrahydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Sivelestat (sodium tetrahydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bestatin (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bestatin (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Flumatinib (mesylate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Flumatinib (mesylate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cabozantinib (S-malate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cabozantinib (S-malate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Chlorhexidine (diacetate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Chlorhexidine (diacetate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxorubicin (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxorubicin (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pentamidine (isethionate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pentamidine (isethionate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Loperamide (hydrochloride)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Loperamide (hydrochloride)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Estrone sulfate (potassium)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Estrone sulfate (potassium)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cloxacillin (sodium)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cloxacillin (sodium)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Bosentan (hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Bosentan (hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pitavastatin (Calcium)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pitavastatin (Calcium)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Edoxaban (tosylate monohydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Edoxaban (tosylate monohydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Almonertinib (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Almonertinib (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Rimonabant (Hydrochloride)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Rimonabant (Hydrochloride)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Fostamatinib (disodium hexahydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Fostamatinib (disodium hexahydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Neratinib (maleate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Neratinib (maleate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Indacaterol (maleate)_NCI-H1792 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Indacaterol (maleate)_NCI-H1792 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Cytarabine (hydrochloride)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Cytarabine (hydrochloride)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Omeprazole (sodium)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Omeprazole (sodium)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tofacitinib (citrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tofacitinib (citrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Entecavir (monohydrate)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Entecavir (monohydrate)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Ropivacaine (hydrochloride monohydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Ropivacaine (hydrochloride monohydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Pexidartinib (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Pexidartinib (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lumateperone (tosylate)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lumateperone (tosylate)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Epirubicin (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Epirubicin (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Procainamide (hydrochloride)_NCI-H23 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Procainamide (hydrochloride)_NCI-H23 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Docetaxel (Trihydrate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Docetaxel (Trihydrate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Tetracycline (hydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Tetracycline (hydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Canagliflozin (hemihydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Canagliflozin (hemihydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Dorzolamide (hydrochloride)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Dorzolamide (hydrochloride)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Lactate (calcium)_NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Lactate (calcium)_NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H661 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H661 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Imiquimod (maleate)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Imiquimod (maleate)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Levobupivacaine (hydrochloride)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Levobupivacaine (hydrochloride)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Erdafitinib _NCI-H2030 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Erdafitinib _NCI-H2030 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
L-Eflornithine (monohydrochloride)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the L-Eflornithine (monohydrochloride)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Quinidine (15% dihydroquinidine)_NCI-H2347 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Quinidine (15% dihydroquinidine)_NCI-H2347 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
LY-2584702 (tosylate salt)_NCI-H596 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the LY-2584702 (tosylate salt)_NCI-H596 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Gallic acid (hydrate)_NCI-H460 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Gallic acid (hydrate)_NCI-H460 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Doxycycline (monohydrate)_NCI-H2122 Gene Set From Tahoe Therapeutics Tahoe 100M Perturbation Atlas genes differentially expressed following the Doxycycline (monohydrate)_NCI-H2122 drug perturbation from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset.
Deficiency of ribose-5-phosphate isomerase Gene Set From ClinVar Gene-Phenotype Associations genes associated with the Deficiency of ribose-5-phosphate isomerase phenotype from the curated ClinVar Gene-Phenotype Associations dataset.
Phosphate transport defect Gene Set From ClinVar Gene-Phenotype Associations genes associated with the Phosphate transport defect phenotype from the curated ClinVar Gene-Phenotype Associations dataset.
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase Gene Set From ClinVar Gene-Phenotype Associations genes associated with the Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase phenotype from the curated ClinVar Gene-Phenotype Associations dataset.
Pyridoxal 5'-phosphate-dependent epilepsy Gene Set From ClinVar Gene-Phenotype Associations genes associated with the Pyridoxal 5'-phosphate-dependent epilepsy phenotype from the curated ClinVar Gene-Phenotype Associations dataset.
Glucose-6-phosphate transport defect Gene Set From ClinVar Gene-Phenotype Associations genes associated with the Glucose-6-phosphate transport defect phenotype from the curated ClinVar Gene-Phenotype Associations dataset.
Mitochondrial phosphate carrier deficiency Gene Set From ClinVar Gene-Phenotype Associations genes associated with the Mitochondrial phosphate carrier deficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset.
Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency Gene Set From ClinVar Gene-Phenotype Associations genes associated with the Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency phenotype from the curated ClinVar Gene-Phenotype Associations dataset.
adenosine phosphate-1622 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the adenosine phosphate-1622 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
adenosine phosphate-6760 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the adenosine phosphate-6760 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
adenosine phosphate-5359 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the adenosine phosphate-5359 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
adenosine phosphate-3237 Gene Set From CMAP Signatures of Differentially Expressed Genes for Small Molecules genes differentially expressed following the adenosine phosphate-3237 small molecule perturbation from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset.
dolichol-phosphate-mannose synthase complex Gene Set From COMPARTMENTS Curated Protein Localization Evidence Scores proteins localized to the dolichol-phosphate-mannose synthase complex cellular component from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
glycerol-3-phosphate dehydrogenase complex Gene Set From COMPARTMENTS Curated Protein Localization Evidence Scores proteins localized to the glycerol-3-phosphate dehydrogenase complex cellular component from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
ribose phosphate diphosphokinase complex Gene Set From COMPARTMENTS Curated Protein Localization Evidence Scores proteins localized to the ribose phosphate diphosphokinase complex cellular component from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset.
alpha,alpha-trehalose-phosphate synthase complex (udp-forming) Gene Set From COMPARTMENTS Text-mining Protein Localization Evidence Scores proteins co-occuring with the alpha,alpha-trehalose-phosphate synthase complex (udp-forming) cellular component in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
carbamoyl-phosphate synthase complex Gene Set From COMPARTMENTS Text-mining Protein Localization Evidence Scores proteins co-occuring with the carbamoyl-phosphate synthase complex cellular component in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
ribose phosphate diphosphokinase complex Gene Set From COMPARTMENTS Text-mining Protein Localization Evidence Scores proteins co-occuring with the ribose phosphate diphosphokinase complex cellular component in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset.
Dolichol-phosphate mannose (DPM) synthase Gene Set From CORUM Protein Complexes proteins in the Dolichol-phosphate mannose (DPM) synthase protein complex from the CORUM Protein Complexes dataset.
Dihydroxyacetone Phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Dihydroxyacetone Phosphate from the curated CTD Gene-Chemical Interactions dataset.
Glyceraldehyde 3-Phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Glyceraldehyde 3-Phosphate from the curated CTD Gene-Chemical Interactions dataset.
pyridoxal phosphate gamma-aminobutyric acid Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical pyridoxal phosphate gamma-aminobutyric acid from the curated CTD Gene-Chemical Interactions dataset.
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid from the curated CTD Gene-Chemical Interactions dataset.
tri-(2-chloroisopropyl)phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tri-(2-chloroisopropyl)phosphate from the curated CTD Gene-Chemical Interactions dataset.
ceramide 1-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical ceramide 1-phosphate from the curated CTD Gene-Chemical Interactions dataset.
tributyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tributyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
pyridoxal phosphate gamma-glutamyl hydrazone Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical pyridoxal phosphate gamma-glutamyl hydrazone from the curated CTD Gene-Chemical Interactions dataset.
triisopropyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical triisopropyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
tri-o-cresyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tri-o-cresyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
hydroxyapatite-beta tricalcium phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical hydroxyapatite-beta tricalcium phosphate from the curated CTD Gene-Chemical Interactions dataset.
tris(chloroethyl)phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tris(chloroethyl)phosphate from the curated CTD Gene-Chemical Interactions dataset.
Pyridoxal Phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Pyridoxal Phosphate from the curated CTD Gene-Chemical Interactions dataset.
sphingosine 1-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical sphingosine 1-phosphate from the curated CTD Gene-Chemical Interactions dataset.
naphthol AS-E phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical naphthol AS-E phosphate from the curated CTD Gene-Chemical Interactions dataset.
diphenylcresyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical diphenylcresyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
dexamethasone 21-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical dexamethasone 21-phosphate from the curated CTD Gene-Chemical Interactions dataset.
triphenyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical triphenyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
Vidarabine Phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Vidarabine Phosphate from the curated CTD Gene-Chemical Interactions dataset.
sodium phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical sodium phosphate from the curated CTD Gene-Chemical Interactions dataset.
dihydrosphingosine 1-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical dihydrosphingosine 1-phosphate from the curated CTD Gene-Chemical Interactions dataset.
calcium phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical calcium phosphate from the curated CTD Gene-Chemical Interactions dataset.
tris(2-ethylhexyl)phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tris(2-ethylhexyl)phosphate from the curated CTD Gene-Chemical Interactions dataset.
glucan phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical glucan phosphate from the curated CTD Gene-Chemical Interactions dataset.
galactose-1-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical galactose-1-phosphate from the curated CTD Gene-Chemical Interactions dataset.
2-deoxyribose 1-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2-deoxyribose 1-phosphate from the curated CTD Gene-Chemical Interactions dataset.
tert-butylphenyl diphenyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tert-butylphenyl diphenyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
di-n-butyl-2,2-dichlorovinyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical di-n-butyl-2,2-dichlorovinyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
2,5-anhydromannitol 1-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 2,5-anhydromannitol 1-phosphate from the curated CTD Gene-Chemical Interactions dataset.
aluminum phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical aluminum phosphate from the curated CTD Gene-Chemical Interactions dataset.
Glucose-6-Phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical Glucose-6-Phosphate from the curated CTD Gene-Chemical Interactions dataset.
ribose-5-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical ribose-5-phosphate from the curated CTD Gene-Chemical Interactions dataset.
phenylsaligenin cyclic phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical phenylsaligenin cyclic phosphate from the curated CTD Gene-Chemical Interactions dataset.
bis(4-nitrophenyl)phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical bis(4-nitrophenyl)phosphate from the curated CTD Gene-Chemical Interactions dataset.
ascorbate-2-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical ascorbate-2-phosphate from the curated CTD Gene-Chemical Interactions dataset.
glucosamine 6-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical glucosamine 6-phosphate from the curated CTD Gene-Chemical Interactions dataset.
polyestradiol phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical polyestradiol phosphate from the curated CTD Gene-Chemical Interactions dataset.
tris(2,3-dibromopropyl)phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tris(2,3-dibromopropyl)phosphate from the curated CTD Gene-Chemical Interactions dataset.
phosphatidylinositol 4-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical phosphatidylinositol 4-phosphate from the curated CTD Gene-Chemical Interactions dataset.
beta-tricalcium phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical beta-tricalcium phosphate from the curated CTD Gene-Chemical Interactions dataset.
clindamycin phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical clindamycin phosphate from the curated CTD Gene-Chemical Interactions dataset.
tris(2-butoxyethyl) phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tris(2-butoxyethyl) phosphate from the curated CTD Gene-Chemical Interactions dataset.
O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
triethyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical triethyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
tri-xylenyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tri-xylenyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical 5-hexyloxy-3',4'-dihydroxy-6,7-dimethoxyflavone 4'-phosphate from the curated CTD Gene-Chemical Interactions dataset.
trimethyl phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical trimethyl phosphate from the curated CTD Gene-Chemical Interactions dataset.
xylulose-5-phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical xylulose-5-phosphate from the curated CTD Gene-Chemical Interactions dataset.
tris(1,3-dichloro-2-propyl)phosphate Gene Set From CTD Gene-Chemical Interactions genes/proteins interacting with the chemical tris(1,3-dichloro-2-propyl)phosphate from the curated CTD Gene-Chemical Interactions dataset.
Mitochondrial Phosphate Carrier Deficiency Gene Set From CTD Gene-Disease Associations genes/proteins associated with the disease Mitochondrial Phosphate Carrier Deficiency from the curated CTD Gene-Disease Associations dataset.
Carbamoyl-Phosphate Synthase I Deficiency Disease Gene Set From CTD Gene-Disease Associations genes/proteins associated with the disease Carbamoyl-Phosphate Synthase I Deficiency Disease from the curated CTD Gene-Disease Associations dataset.
HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY Gene Set From CTD Gene-Disease Associations genes/proteins associated with the disease HEMOLYTIC ANEMIA, NONSPHEROCYTIC, DUE TO GLUCOSE PHOSPHATE ISOMERASE DEFICIENCY from the curated CTD Gene-Disease Associations dataset.
Ribose 5-Phosphate Isomerase Deficiency Gene Set From CTD Gene-Disease Associations genes/proteins associated with the disease Ribose 5-Phosphate Isomerase Deficiency from the curated CTD Gene-Disease Associations dataset.
Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency Gene Set From CTD Gene-Disease Associations genes/proteins associated with the disease Pyridoxamine 5-Prime-Phosphate Oxidase Deficiency from the curated CTD Gene-Disease Associations dataset.
carbamoyl phosphate synthetase i deficiency disease Gene Set From DISEASES Text-mining Gene-Disease Association Evidence Scores genes co-occuring with the disease carbamoyl phosphate synthetase i deficiency disease in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores dataset.
4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the 4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate drug from the curated DrugBank Drug Targets dataset.
D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
4-Nitrophenyl Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the 4-Nitrophenyl Phosphate drug from the curated DrugBank Drug Targets dataset.
Sorbitol 6-phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Sorbitol 6-phosphate drug from the curated DrugBank Drug Targets dataset.
2-Deoxy-2-Amino Glucitol-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the 2-Deoxy-2-Amino Glucitol-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
Alpha-D-Glucose-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Alpha-D-Glucose-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate) Gene Set From DrugBank Drug Targets interacting proteins for the 2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate) drug from the curated DrugBank Drug Targets dataset.
Glyceraldehyde-3-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Glyceraldehyde-3-Phosphate drug from the curated DrugBank Drug Targets dataset.
1-3 Sugar Ring of Pentamannosyl 6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the 1-3 Sugar Ring of Pentamannosyl 6-Phosphate drug from the curated DrugBank Drug Targets dataset.
Fructose-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Fructose-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
3'-Phosphate-Adenosine-5'-Diphosphate Gene Set From DrugBank Drug Targets interacting proteins for the 3'-Phosphate-Adenosine-5'-Diphosphate drug from the curated DrugBank Drug Targets dataset.
Erythose-4-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Erythose-4-Phosphate drug from the curated DrugBank Drug Targets dataset.
L-Myo-Inositol-1-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the L-Myo-Inositol-1-Phosphate drug from the curated DrugBank Drug Targets dataset.
Pyridoxine-5'-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Pyridoxine-5'-Phosphate drug from the curated DrugBank Drug Targets dataset.
L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate drug from the curated DrugBank Drug Targets dataset.
2-Deoxy-Glucitol-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the 2-Deoxy-Glucitol-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
Heptulose-2-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Heptulose-2-Phosphate drug from the curated DrugBank Drug Targets dataset.
Pyridoxamine-5'-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Pyridoxamine-5'-Phosphate drug from the curated DrugBank Drug Targets dataset.
[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the [(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate drug from the curated DrugBank Drug Targets dataset.
Glucose-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Glucose-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
Histamine Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Histamine Phosphate drug from the curated DrugBank Drug Targets dataset.
Ribose-1-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Ribose-1-Phosphate drug from the curated DrugBank Drug Targets dataset.
Alpha-D-Glucose-1-Phosphate-6-Vanadate Gene Set From DrugBank Drug Targets interacting proteins for the Alpha-D-Glucose-1-Phosphate-6-Vanadate drug from the curated DrugBank Drug Targets dataset.
Thymidine-5'-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Thymidine-5'-Phosphate drug from the curated DrugBank Drug Targets dataset.
6-Hydroxyuridine-5'-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the 6-Hydroxyuridine-5'-Phosphate drug from the curated DrugBank Drug Targets dataset.
Pyridoxal Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Pyridoxal Phosphate drug from the curated DrugBank Drug Targets dataset.
Alpha-D-Glucose-1-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Alpha-D-Glucose-1-Phosphate drug from the curated DrugBank Drug Targets dataset.
Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate drug from the curated DrugBank Drug Targets dataset.
Ethyl Dihydrogen Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Ethyl Dihydrogen Phosphate drug from the curated DrugBank Drug Targets dataset.
2-Deoxy-Glucose-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the 2-Deoxy-Glucose-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
Alpha-D-Mannose-6-Phosphate Gene Set From DrugBank Drug Targets interacting proteins for the Alpha-D-Mannose-6-Phosphate drug from the curated DrugBank Drug Targets dataset.
3'-THIO-THYMIDINE-5'-PHOSPHATE Gene Set From DrugBank Drug Targets interacting proteins for the 3'-THIO-THYMIDINE-5'-PHOSPHATE drug from the curated DrugBank Drug Targets dataset.
phosphate serum levels Gene Set From GAD Gene-Disease Associations genes associated with the disease phosphate serum levels in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
undetectable glucose-6-phosphate dehydrogenase enzyme activity Gene Set From GAD Gene-Disease Associations genes associated with the disease undetectable glucose-6-phosphate dehydrogenase enzyme activity in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset.
phosphate Gene Set From GeneRIF Biological Term Annotations genes co-occuring with the biological term phosphate in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
glycerol-3-phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the glycerol-3-phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
renal phosphate ion absorption Gene Set From GO Biological Process Annotations 2015 genes participating in the renal phosphate ion absorption biological process from the curated GO Biological Process Annotations 2015 dataset.
glucose-6-phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the glucose-6-phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
pentose-phosphate shunt, non-oxidative branch Gene Set From GO Biological Process Annotations 2015 genes participating in the pentose-phosphate shunt, non-oxidative branch biological process from the curated GO Biological Process Annotations 2015 dataset.
positive regulation of sodium-dependent phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the positive regulation of sodium-dependent phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
pyridoxal 5'-phosphate salvage Gene Set From GO Biological Process Annotations 2015 genes participating in the pyridoxal 5'-phosphate salvage biological process from the curated GO Biological Process Annotations 2015 dataset.
glucose 6-phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the glucose 6-phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
phosphatidylinositol-3-phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the phosphatidylinositol-3-phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
glycerol-3-phosphate catabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the glycerol-3-phosphate catabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
regulation of phosphate transmembrane transport Gene Set From GO Biological Process Annotations 2015 genes participating in the regulation of phosphate transmembrane transport biological process from the curated GO Biological Process Annotations 2015 dataset.
fructose 6-phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the fructose 6-phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
inositol phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the inositol phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
regulation of pentose-phosphate shunt Gene Set From GO Biological Process Annotations 2015 genes participating in the regulation of pentose-phosphate shunt biological process from the curated GO Biological Process Annotations 2015 dataset.
positive regulation of inositol phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the positive regulation of inositol phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
regulation of sodium-dependent phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the regulation of sodium-dependent phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
inositol phosphate dephosphorylation Gene Set From GO Biological Process Annotations 2015 genes participating in the inositol phosphate dephosphorylation biological process from the curated GO Biological Process Annotations 2015 dataset.
deoxyribose phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the deoxyribose phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
phosphate ion homeostasis Gene Set From GO Biological Process Annotations 2015 genes participating in the phosphate ion homeostasis biological process from the curated GO Biological Process Annotations 2015 dataset.
pyridoxal phosphate catabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the pyridoxal phosphate catabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
regulation of renal phosphate excretion Gene Set From GO Biological Process Annotations 2015 genes participating in the regulation of renal phosphate excretion biological process from the curated GO Biological Process Annotations 2015 dataset.
inositol phosphate catabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the inositol phosphate catabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
glycerol-3-phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the glycerol-3-phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
ceramide 1-phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the ceramide 1-phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
regulation of inositol phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the regulation of inositol phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
hexose phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the hexose phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
nucleoside phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the nucleoside phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
regulation of phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the regulation of phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
negative regulation of renal phosphate excretion Gene Set From GO Biological Process Annotations 2015 genes participating in the negative regulation of renal phosphate excretion biological process from the curated GO Biological Process Annotations 2015 dataset.
pyridoxal phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the pyridoxal phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
nucleoside phosphate catabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the nucleoside phosphate catabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
phosphate-containing compound metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the phosphate-containing compound metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
positive regulation of phosphate transmembrane transport Gene Set From GO Biological Process Annotations 2015 genes participating in the positive regulation of phosphate transmembrane transport biological process from the curated GO Biological Process Annotations 2015 dataset.
glyceraldehyde-3-phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the glyceraldehyde-3-phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
deoxyribose phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the deoxyribose phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
sphinganine-1-phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the sphinganine-1-phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
nucleoside phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the nucleoside phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
pyridoxal phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the pyridoxal phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
deoxyribose phosphate catabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the deoxyribose phosphate catabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
pentose-phosphate shunt Gene Set From GO Biological Process Annotations 2015 genes participating in the pentose-phosphate shunt biological process from the curated GO Biological Process Annotations 2015 dataset.
carbamoyl phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the carbamoyl phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
positive regulation of phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the positive regulation of phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
inositol phosphate-mediated signaling Gene Set From GO Biological Process Annotations 2015 genes participating in the inositol phosphate-mediated signaling biological process from the curated GO Biological Process Annotations 2015 dataset.
glucose 1-phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the glucose 1-phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
negative regulation of inositol phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the negative regulation of inositol phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
phosphate ion transport Gene Set From GO Biological Process Annotations 2015 genes participating in the phosphate ion transport biological process from the curated GO Biological Process Annotations 2015 dataset.
sodium-dependent phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the sodium-dependent phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
inositol phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the inositol phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
ribose phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the ribose phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
sphingosine-1-phosphate signaling pathway Gene Set From GO Biological Process Annotations 2015 genes participating in the sphingosine-1-phosphate signaling pathway biological process from the curated GO Biological Process Annotations 2015 dataset.
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
carbamoyl phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the carbamoyl phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
phosphate ion transmembrane transport Gene Set From GO Biological Process Annotations 2015 genes participating in the phosphate ion transmembrane transport biological process from the curated GO Biological Process Annotations 2015 dataset.
negative regulation of sodium-dependent phosphate transport Gene Set From GO Biological Process Annotations 2015 genes participating in the negative regulation of sodium-dependent phosphate transport biological process from the curated GO Biological Process Annotations 2015 dataset.
cellular phosphate ion homeostasis Gene Set From GO Biological Process Annotations 2015 genes participating in the cellular phosphate ion homeostasis biological process from the curated GO Biological Process Annotations 2015 dataset.
negative regulation of phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the negative regulation of phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
ribose phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the ribose phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
cellular response to phosphate starvation Gene Set From GO Biological Process Annotations 2015 genes participating in the cellular response to phosphate starvation biological process from the curated GO Biological Process Annotations 2015 dataset.
protein-pyridoxal-5-phosphate linkage Gene Set From GO Biological Process Annotations 2015 genes participating in the protein-pyridoxal-5-phosphate linkage biological process from the curated GO Biological Process Annotations 2015 dataset.
glyceraldehyde-3-phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the glyceraldehyde-3-phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
sphinganine-1-phosphate biosynthetic process Gene Set From GO Biological Process Annotations 2015 genes participating in the sphinganine-1-phosphate biosynthetic process biological process from the curated GO Biological Process Annotations 2015 dataset.
regulation of phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the regulation of phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
alditol phosphate metabolic process Gene Set From GO Biological Process Annotations 2015 genes participating in the alditol phosphate metabolic process biological process from the curated GO Biological Process Annotations 2015 dataset.
pentose-phosphate shunt, oxidative branch Gene Set From GO Biological Process Annotations 2015 genes participating in the pentose-phosphate shunt, oxidative branch biological process from the curated GO Biological Process Annotations 2015 dataset.
dolichol-phosphate-mannose synthase complex Gene Set From GO Cellular Component Annotations 2015 proteins localized to the dolichol-phosphate-mannose synthase complex cellular component from the curated GO Cellular Component Annotations 2015 dataset.
glycerol-3-phosphate dehydrogenase complex Gene Set From GO Cellular Component Annotations 2015 proteins localized to the glycerol-3-phosphate dehydrogenase complex cellular component from the curated GO Cellular Component Annotations 2015 dataset.
ribose phosphate diphosphokinase complex Gene Set From GO Cellular Component Annotations 2015 proteins localized to the ribose phosphate diphosphokinase complex cellular component from the curated GO Cellular Component Annotations 2015 dataset.
phosphate ion transmembrane transporter activity Gene Set From GO Molecular Function Annotations 2015 genes performing the phosphate ion transmembrane transporter activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
thiamine phosphate phosphatase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the thiamine phosphate phosphatase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
phosphate ion binding Gene Set From GO Molecular Function Annotations 2015 genes performing the phosphate ion binding molecular function from the curated GO Molecular Function Annotations 2015 dataset.
nucleoside phosphate kinase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the nucleoside phosphate kinase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
pyridoxamine-phosphate oxidase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the pyridoxamine-phosphate oxidase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
phosphatidylinositol phosphate 5-phosphatase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the phosphatidylinositol phosphate 5-phosphatase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glutamine-fructose-6-phosphate transaminase (isomerizing) activity Gene Set From GO Molecular Function Annotations 2015 genes performing the glutamine-fructose-6-phosphate transaminase (isomerizing) activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
1-phosphatidylinositol-3-phosphate 5-kinase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the 1-phosphatidylinositol-3-phosphate 5-kinase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
phosphatidylinositol phosphate 4-phosphatase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the phosphatidylinositol phosphate 4-phosphatase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glycerol-3-phosphate dehydrogenase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the glycerol-3-phosphate dehydrogenase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glycogen synthase activity, transferring glucose-1-phosphate Gene Set From GO Molecular Function Annotations 2015 genes performing the glycogen synthase activity, transferring glucose-1-phosphate molecular function from the curated GO Molecular Function Annotations 2015 dataset.
phosphotransferase activity, phosphate group as acceptor Gene Set From GO Molecular Function Annotations 2015 genes performing the phosphotransferase activity, phosphate group as acceptor molecular function from the curated GO Molecular Function Annotations 2015 dataset.
dolichyl-phosphate beta-glucosyltransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the dolichyl-phosphate beta-glucosyltransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
ceramide 1-phosphate binding Gene Set From GO Molecular Function Annotations 2015 genes performing the ceramide 1-phosphate binding molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glucosamine-6-phosphate deaminase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the glucosamine-6-phosphate deaminase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
udp-n-acetylglucosamine-dolichyl-phosphate n-acetylglucosaminephosphotransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the udp-n-acetylglucosamine-dolichyl-phosphate n-acetylglucosaminephosphotransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
1-phosphatidylinositol-4-phosphate 5-kinase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the 1-phosphatidylinositol-4-phosphate 5-kinase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
fructose-1-phosphate aldolase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the fructose-1-phosphate aldolase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glucosamine 6-phosphate n-acetyltransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the glucosamine 6-phosphate n-acetyltransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
mannose-phosphate guanylyltransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the mannose-phosphate guanylyltransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
triose-phosphate isomerase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the triose-phosphate isomerase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
lysine n-acetyltransferase activity, acting on acetyl phosphate as donor Gene Set From GO Molecular Function Annotations 2015 genes performing the lysine n-acetyltransferase activity, acting on acetyl phosphate as donor molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glyceraldehyde-3-phosphate dehydrogenase (nad+) (phosphorylating) activity Gene Set From GO Molecular Function Annotations 2015 genes performing the glyceraldehyde-3-phosphate dehydrogenase (nad+) (phosphorylating) activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
sodium-dependent phosphate transmembrane transporter activity Gene Set From GO Molecular Function Annotations 2015 genes performing the sodium-dependent phosphate transmembrane transporter activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
phosphatidylinositol-4-phosphate binding Gene Set From GO Molecular Function Annotations 2015 genes performing the phosphatidylinositol-4-phosphate binding molecular function from the curated GO Molecular Function Annotations 2015 dataset.
fucose-1-phosphate guanylyltransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the fucose-1-phosphate guanylyltransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
1-phosphatidylinositol-4-phosphate 3-kinase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the 1-phosphatidylinositol-4-phosphate 3-kinase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
ceramide 1-phosphate transporter activity Gene Set From GO Molecular Function Annotations 2015 genes performing the ceramide 1-phosphate transporter activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
ethanolamine-phosphate phospho-lyase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the ethanolamine-phosphate phospho-lyase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glucose-6-phosphate transmembrane transporter activity Gene Set From GO Molecular Function Annotations 2015 genes performing the glucose-6-phosphate transmembrane transporter activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
ribose phosphate diphosphokinase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the ribose phosphate diphosphokinase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
glycerone-phosphate o-acyltransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the glycerone-phosphate o-acyltransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
dolichyl-phosphate beta-d-mannosyltransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the dolichyl-phosphate beta-d-mannosyltransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity Gene Set From GO Molecular Function Annotations 2015 genes performing the carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
pantetheine-phosphate adenylyltransferase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the pantetheine-phosphate adenylyltransferase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
nucleoside phosphate binding Gene Set From GO Molecular Function Annotations 2015 genes performing the nucleoside phosphate binding molecular function from the curated GO Molecular Function Annotations 2015 dataset.
inorganic phosphate transmembrane transporter activity Gene Set From GO Molecular Function Annotations 2015 genes performing the inorganic phosphate transmembrane transporter activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
carbamoyl-phosphate synthase (ammonia) activity Gene Set From GO Molecular Function Annotations 2015 genes performing the carbamoyl-phosphate synthase (ammonia) activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
orotidine-5'-phosphate decarboxylase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the orotidine-5'-phosphate decarboxylase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
phosphatidylinositol-4-phosphate phosphatase activity Gene Set From GO Molecular Function Annotations 2015 genes performing the phosphatidylinositol-4-phosphate phosphatase activity molecular function from the curated GO Molecular Function Annotations 2015 dataset.
pyridoxal phosphate binding Gene Set From GO Molecular Function Annotations 2015 genes performing the pyridoxal phosphate binding molecular function from the curated GO Molecular Function Annotations 2015 dataset.
peptidyl-lysine n-acetyltransferase activity, acting on acetyl phosphate as donor Gene Set From GO Molecular Function Annotations 2015 genes performing the peptidyl-lysine n-acetyltransferase activity, acting on acetyl phosphate as donor molecular function from the curated GO Molecular Function Annotations 2015 dataset.

Harmonizome 3.0

Rucaparib (phosphate)_NCI-H1573 Gene Set

Rucaparib (phosphate)_NCI-H1792 Gene Set

Rucaparib (phosphate)_NCI-H2122 Gene Set

Rucaparib (phosphate)_NCI-H596 Gene Set

Rucaparib (phosphate)_NCI-H2030 Gene Set

Rucaparib (phosphate)_NCI-H2347 Gene Set

Rucaparib (phosphate)_NCI-H661 Gene Set

Rucaparib (phosphate)_NCI-H460 Gene Set

Rucaparib (phosphate)_NCI-H23 Gene Set

Rucaparib (phosphate)_C32 Gene Set

Rucaparib (phosphate)_HepG2/C3A Gene Set

Rucaparib (phosphate)_SW 900 Gene Set

Rucaparib (phosphate)_LOX-IMVI Gene Set

Rucaparib (phosphate)_A-172 Gene Set

Rucaparib (phosphate)_BT-474 Gene Set

Rucaparib (phosphate)_LS 180 Gene Set

Rucaparib (phosphate)_CFPAC-1 Gene Set

Rucaparib (phosphate)_Hs 766T Gene Set

Rucaparib (phosphate)_SK-MEL-2 Gene Set

Rucaparib (phosphate)_A498 Gene Set

Rucaparib (phosphate)_HT-29 Gene Set

Rucaparib (phosphate)_HEC-1-A Gene Set

Rucaparib (phosphate)_A549 Gene Set

Rucaparib (phosphate)_AsPC-1 Gene Set

Rucaparib (phosphate)_SNU-423 Gene Set

Rucaparib (phosphate)_SHP-77 Gene Set

Rucaparib (phosphate)_A-427 Gene Set

Rucaparib (phosphate)_CHP-212 Gene Set

Rucaparib (phosphate)_MIA PaCa-2 Gene Set

Rucaparib (phosphate)_HOP62 Gene Set

Rucaparib (phosphate)_HS-578T Gene Set

Rucaparib (phosphate)_SW1417 Gene Set

Rucaparib (phosphate)_SW480 Gene Set

Rucaparib (phosphate)_RKO Gene Set

Rucaparib (phosphate)_PANC-1 Gene Set

Rucaparib (phosphate)_J82 Gene Set

Rucaparib (phosphate)_hTERT-HPNE Gene Set

Rucaparib (phosphate)_C-33 A Gene Set

Rucaparib (phosphate)_AN3 CA Gene Set

Rucaparib (phosphate)_SW 1088 Gene Set

Rucaparib (phosphate)_LoVo Gene Set

Rucaparib (phosphate)_KATO III Gene Set

Rucaparib (phosphate)_Panc 03.27 Gene Set

Rucaparib (phosphate)_HCT15 Gene Set

Rucaparib (phosphate)_SW 1271 Gene Set

Rucaparib (phosphate)_H4 Gene Set

Rucaparib (phosphate)_RPMI-7951 Gene Set

Rucaparib (phosphate)_COLO 205 Gene Set

Rucaparib (phosphate)_SW48 Gene Set

Rucaparib (phosphate)_SNU-1 Gene Set

RUCAPARIB PHOSPHATE Gene Set

Rucaparib Gene Set

RUCAPARIB Gene Set

RUCAPARIB METABOLITE M324 Gene Set

RUCAPARIB CAMSYLATE Gene Set

Benproperine (phosphate)_NCI-H2030 Gene Set

Benproperine (phosphate)_NCI-H2347 Gene Set

Benproperine (phosphate)_NCI-H1792 Gene Set

Benproperine (phosphate)_NCI-H460 Gene Set

Benproperine (phosphate)_NCI-H23 Gene Set

Benproperine (phosphate)_NCI-H661 Gene Set

Benproperine (phosphate)_NCI-H2122 Gene Set

Benproperine (phosphate)_NCI-H596 Gene Set

adenosine 3'-phosphate-5'-phosphate Gene Set

3'-Phosphate-Adenosine-5'-Phosphate Sulfate Gene Set

protein-pyridoxal-5-phosphate linkage via peptidyl-n6-pyridoxal phosphate-l-lysine Gene Set

sedoheptulose-7-phosphate:d-glyceraldehyde-3-phosphate glyceronetransferase activity Gene Set

Glycerol-3-phosphate O-acyltransferase/Dihydroxyacetone phosphate acyltransferase Gene Set

protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine Gene Set

fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate Gene Set

tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate Gene Set

glucose 6-phosphate:inorganic phosphate antiporter activity Gene Set

hexose-phosphate:inorganic phosphate antiporter activity Gene Set

protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine Gene Set

fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate Gene Set

glucose 6-phosphate:phosphate antiporter activity Gene Set

hexose-phosphate:phosphate antiporter activity Gene Set

deoxynucleoside-phosphate kinase activity, ATP as phosphate donor Gene Set

(R)-Verapamil (hydrochloride)_NCI-H460 Gene Set